MEPs give formal backing to Commission’s next big research programme – and want to spend more than the €94.1B already proposed. Several members states oppose that, setting scene for at least another year of wrangling
Some medicines may carry a higher risk of side effects for the lungs than previously thought, IMI research reveals. The drugs studied work well for most, but doctors should monitor patients for side effects.
In 2018, Chinese companies spent on R&D 20 per cent more than in 2017. EU corporate R&D investment is growing at a much slower pace, with companies spending only 5.5 per cent more than the previous year. Read more
Meeting of member states’ research delegations this week in Brussels saw further disagreement over the direction of Horizon Europe. And a proposed mission to build a universal quantum computer is scratched
US tech companies are raiding our computer science departments. A new initiative, Ellis, wants to give researchers a reason to stay in academe and in Europe. Meanwhile, the Commission is putting flesh on its AI plans
Europe’s big open science cloud project is formally getting underway, with the launch of its Governing Board. In this white paper, a cross-sector group of experts – from academia, industry and public-sector institutions – offers its suggestions on which issues need tackling first.